Category: Multiple Sclerosis (MS) Symptoms

What is the Modified Fatigue Impact Scale?

The Modified Fatigue Impact Scale (MFIS) is a tool that doctors use to evaluate how fatigueaffects someone’s life. Fatigue is a…

Stuart Schlossman

MS Fatigue: What to Know

Medically reviewed by Seunggu Han, MD — Written by Jacquelyn Cafasso on March 14, 2019 While most people associate multiple…

Stuart Schlossman

Use of the Multiple Sclerosis Functional Composite to predict disability in relapsing MS

Abstract Objective: To determine whether the MS Functional Composite (MSFC) can predict future disease progression in patients with relapsing remitting…

Stuart Schlossman

Lhermitte’s Sign: What Is It? How Do You Treat It?

ARTICLES ONMULTIPLE SCLEROSIS PAIN MS Pain Dysesthesia Spasticity MS Hug  Lhermitte’s Sign It lasts just a few seconds, but it…

Stuart Schlossman

Anxiety, Depression Contribute to Multiple Sclerosis Impaired Cognition

Anxiety and depression could both contribute to the impaired cognition of patients with multiple sclerosis (MS), according to a recent study…

Stuart Schlossman

Tame Your Bladder When You Have MS

If multiple sclerosis symptoms make you head to the bathroom more often than you’d like, try some simple tips that…

Stuart Schlossman

Paroxysmal Symptoms of MS: Elusive but Real

 Some symptoms of MS come and go quickly, in minutes or even seconds.  By Mona Sen Sudden walking difficulties are an…

Stuart Schlossman

7 Strange and Unusual Symptoms of Multiple Sclerosis

Multiple sclerosis (MS) is a disease which is unique to each patient, which means no two people suffer from identical symptoms.…

Stuart Schlossman

An MS patient’s story: How Secondary-Progressive MS Puts Me in a Whole New Place

Personal Takes Compared with life with relapsing-remitting MS, SPMS feels like an entirely different environment.  By Mona Sen Accepting the changes…

Stuart Schlossman

#Ampyra Significantly Improves Walking Ability As Reported by MS Patients, Phase 3 Trial Shows

December 19, 2018 Treatment with Ampyra (dalfampridine) for 24 weeks leads to sustained and clinically meaningful improvements in walking ability as reported…

Stuart Schlossman

Categories

Latest Blog Posts